Nick joined MedAvante in 2012 and established the MedAvante-ProPhase Asia Pacific office in Tokyo, Japan. In early 2019, he was promoted to his new role as Regional Executive – Asia Pacific. In this role, Nick oversees WCG’s robust suite of transformational solutions and manages the growth, development, and operational strategy relating to these services in the Asia Pacific region. With over 15 years in clinical research, Nick is an expert in clinical business strategy, transformation, innovation, pharmaceutical efficiency, and clinical research operations.Before joining MedAvante, Nick spent the majority of his career at Asia Pacific CRO, where he held a variety of strategic roles in clinical operations, project management, and business development. He spent the early part of his career in Business Development of clinical trials in Asia. This experience was followed by the running of regional clinical trials in oncology, hematology, cardiovascular, and neurology compounds. As he moved into more strategic roles, he provided executive level guidance and led a team of scientific, operational, and medical experts to bring about customized, practical and evidence-based solutions